Company Filing History:
Years Active: 2013
Title: Takahiro Hatakeyama: Innovator in Pharmaceutical Crystallography
Introduction
Takahiro Hatakeyama is a notable inventor based in Kodama-gun, Japan. He has made significant contributions to the field of pharmaceutical crystallography, particularly through his innovative work on stable crystal forms of important compounds.
Latest Patents
Hatakeyama holds a patent for a stable crystal of 1-(2'-cyano-2′-deoxy-β-D-arabinofuranosyl)cytosine monohydrochloride. This patent discloses a stable crystal that exhibits characteristic peaks at diffraction angles of 13.7°, 15.7°, 16.0°, 18.6°, 20.3°, and 22.7° as measured by powder X-ray diffraction. The crystal has a melting point ranging from 192°C to 197°C, showcasing its stability and potential applications in pharmaceuticals.
Career Highlights
Takahiro Hatakeyama is currently associated with Delta-fly Pharma, Inc., where he continues to advance his research and development efforts. His work is pivotal in enhancing the understanding of crystalline forms of pharmaceutical compounds, which can lead to improved drug formulations.
Collaborations
Hatakeyama collaborates with Shotaro Watanabe, contributing to the innovative research environment at Delta-fly Pharma, Inc. Their combined expertise fosters advancements in the field of pharmaceutical sciences.
Conclusion
Takahiro Hatakeyama's contributions to the field of pharmaceutical crystallography are noteworthy, particularly through his patented work on stable crystal forms. His ongoing research at Delta-fly Pharma, Inc. continues to impact the pharmaceutical industry positively.